Vitamin D2 alone or with calcitriol for children with liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This trial compares two types of vitamin D—one is plain vitamin D2, the other is vitamin D2 plus a more active form (calcitriol)—to see which works better for children with liver problems and low vitamin D levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 18 years old.
- Your child must have a liver condition called cholestasis (bile flow blockage) with high direct bilirubin for over a month.
- Your child must have low vitamin D levels (below 20 ng/mL) in their blood.
- Your child must not have high calcium in their urine (tested before the study).
- Your child must not be taking seizure medication (anticonvulsants).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether giving a higher dose of vitamin D3 helps children and teens with inflammatory bowel disease (Crohn’s or ulcerative colitis) who have low vitamin D levels. Participants are already on biologic medicines and will be treated while monitoring blood (and safety) related to vitamin D.
This study compares different forms of vitamin D3 to find which works best for adults with low vitamin D levels. If you have a vitamin D deficiency and are generally healthy, this trial may help determine the most effective supplement for you.
This trial is testing whether giving preterm babies (born at 24 to 32 weeks) a high, carefully monitored dose of vitamin D right after birth helps improve their health compared to standard care.
This trial tests whether taking vitamin D by mouth can lower the risk of peritonitis (a painful infection of the lining around the abdomen) in people on peritoneal dialysis. You might benefit if your vitamin D level is low and you meet other safety requirements.
This trial tests whether giving a high dose of vitamin D3 can reduce death within 28 days for critically ill adults in the ICU who have very low vitamin D levels. It may help by correcting vitamin D deficiency, which the study team thinks could affect outcomes in serious illness.
This trial tests whether starting vitamin D3 soon after ICU admission helps critically ill adults with low vitamin D levels. It may help correct low vitamin D and possibly improve recovery, depending on your health situation.
Hear when a new Cholestatic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.